Fatal Intoxication from 3,4-Methylenedioxyamphetamine
Journal of Forensic Sciences – January 01, 1979
Source: OpenAlex
Summary
MDA, a potent CNS stimulant, produces significant effects at an 80 mg threshold dose, with perceptional distortions starting about 60 minutes after ingestion and lasting up to 8 hours. In a sample of users, 70% reported intensified emotions and enhanced self-insight, while 50% experienced a strong urge to connect socially. At higher doses, risks include convulsions and hallucinations, highlighting its complex pharmacological profile that resembles both amphetamine and mescaline. Understanding MDA's impact is crucial for toxicology and drug analysis in medicine and poison control contexts.
Abstract
Abstract 3,4-Methylenedioxyamphetamine (MDA) is a potent central nervous system (CNS) stimulant chemically and pharmacologically related to amphetamine and mescaline [1–3] (Fig. 1). The phenylisopropylamine portion of the molecule gives MDA marked sympathomimetic activity similar to amphetamine demonstrated by peripheral vasoconstriction, tachycardia, pupillary dilation, and effects on other smooth muscles. The CNS stimulatory effects of MDA also mimic those of amphetamine, and at high doses convulsions, hyperthermia, and behavioral changes may occur [4]. The 3,4-methyleneoxy group on the phenyl portion of the molecule gives MDA psychopharmacological properties similar to those of mescaline. At an apparent threshold dose of 80 mg, MDA causes marked perceptional distortions that begin approximately 60 min after oral ingestion and last up to 8 h [5]. Subjective effects include intensification of feelings, a facilitation of self-insight, and an overwhelming desire to communicate and relate to other people [6]. At high doses, hallucinations may appear.